rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2003-9-9
|
pubmed:abstractText |
Palliative treatment for nondisseminated unresectable peripheral cholangiocarcinoma (PCC) carries a 0% 5-year survival rate. The role of orthotopic liver transplantation (OLT) in these patients is controversial because the survival rate is lower than with other indications for transplantation and the lack of available donor organs. The aim of this paper was to review the Spanish experience in OLT for PCC to identify prognostic factors for survival.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0041-1345
|
pubmed:author |
pubmed-author:BernardosAA,
pubmed-author:CallejaJJ,
pubmed-author:FernándezJ AJA,
pubmed-author:FiguerasJJ,
pubmed-author:FleirasMM,
pubmed-author:GómezMM,
pubmed-author:Garcia-ValdelcasasJ CJC,
pubmed-author:JaurrietaEE,
pubmed-author:LópezPP,
pubmed-author:LoinazCC,
pubmed-author:MarínCC,
pubmed-author:MargaritCC,
pubmed-author:MoyaAA,
pubmed-author:ParrillaPP,
pubmed-author:RoblesRR,
pubmed-author:SantoyoJJ,
pubmed-author:TurriónV SVS,
pubmed-author:ValdiviesoAA,
pubmed-author:VasePP,
pubmed-author:de VicenteEE
|
pubmed:issnType |
Print
|
pubmed:volume |
35
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1823-4
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12962809-Bile Duct Neoplasms,
pubmed-meshheading:12962809-Bile Ducts, Intrahepatic,
pubmed-meshheading:12962809-Cholangiocarcinoma,
pubmed-meshheading:12962809-Follow-Up Studies,
pubmed-meshheading:12962809-Humans,
pubmed-meshheading:12962809-Liver Transplantation,
pubmed-meshheading:12962809-Neoplasm Metastasis,
pubmed-meshheading:12962809-Palliative Care,
pubmed-meshheading:12962809-Recurrence,
pubmed-meshheading:12962809-Retrospective Studies,
pubmed-meshheading:12962809-Survival Analysis,
pubmed-meshheading:12962809-Time Factors
|
pubmed:year |
2003
|
pubmed:articleTitle |
Liver transplantation for peripheral cholangiocarcinoma: Spanish experience.
|
pubmed:affiliation |
Virgen de la Arrixaca University Hospital, Murcia, Spain. rirocam@um.es
|
pubmed:publicationType |
Journal Article,
Comparative Study
|